FDA Clearance Tracker · P080014-S018
CERVISTA HPV HR AND GENFIND KIT
Last checked: Nov 20, 2026Latest source record: Apr 29, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Apr 29, 2014
Approved
Time to decision
272 days
Received Jul 31, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080014-S018
- Device name
- CERVISTA HPV HR AND GENFIND KIT
- Applicant
- Hologic, Inc.
- Applicant location
- Marlborough, MA
- Received
- Jul 31, 2013
- Decided
- Apr 29, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P080014
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A POST APPROVAL STUDY LABELING UPDATE.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.